Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Melatonin Treatment on Blood Pressure Circadian Rhythm, Sleep and Metabolic Variables
NCT06380491Phase 4Recruiting
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Jun 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in Insomnia, obstructive sleep apnea (OSA), hypertension (HTN), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started Jun 2023; status: recruiting.
02
Drugs
melatonin
03
Conditions
Insomniaobstructive sleep apnea (OSA)hypertension (HTN)
Beyond the preview
Go deeper on NCT06380491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06380491.